Steris Plc (NYSE:STE) Earns Daily News Impact Score of 0.12
News headlines about Steris Plc (NYSE:STE) have been trending somewhat positive on Friday, according to Accern Sentiment. The research firm scores the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Steris Plc earned a news sentiment score of 0.12 on Accern’s scale. Accern also gave news stories about the medical equipment provider an impact score of 47.76160677193 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
Here are some of the news stories that may have impacted Accern’s analysis:
- Insider Selling: Steris Plc (NYSE:STE) Director Sells 2,744 Shares of Stock (americanbankingnews.com)
- STERIS plc Ordinary Shares (STE) Holdings Increased by Alliancebernstein L.P. (highlightpress.com)
- IHS Markit Score downgrades Steris PLC to 64 out of 100, ranking positively in only one out of three available IHS Markit categories. (finance.yahoo.com)
- Alliancebernstein L.P. Buys A Lot More STERIS plc Ordinary Shares (STE) Stock (highlightpress.com)
- STERIS PLC (NYSE:STE) Expected to Post Quarterly Sales of $622.87 Million (americanbankingnews.com)
Several equities research analysts recently weighed in on the company. Wellington Shields cut Steris Plc from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. BidaskClub cut Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Raymond James Financial, Inc. increased their target price on Steris Plc from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday. Zacks Investment Research upgraded Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 target price for the company in a report on Tuesday, July 11th. Finally, KeyCorp upgraded Steris Plc from a “sector weight” rating to an “overweight” rating and set a $89.00 target price for the company in a report on Wednesday, May 3rd. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $86.75.
Steris Plc (NYSE STE) traded up 0.35% on Friday, reaching $84.94. The company’s stock had a trading volume of 358,659 shares. Steris Plc has a one year low of $63.80 and a one year high of $87.49. The firm has a 50-day moving average of $82.58 and a 200-day moving average of $75.07. The company has a market capitalization of $7.24 billion, a PE ratio of 60.76 and a beta of 1.33.
Steris Plc (NYSE:STE) last announced its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.80 by $0.05. Steris Plc had a return on equity of 11.39% and a net margin of 4.63%. The business had revenue of $608 million during the quarter, compared to analyst estimates of $597.66 million. During the same quarter in the previous year, the business earned $0.79 earnings per share. The company’s revenue for the quarter was down 4.8% compared to the same quarter last year. Analysts predict that Steris Plc will post $4.06 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be given a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a dividend yield of 1.46%. The ex-dividend date is Friday, August 25th. This is a positive change from Steris Plc’s previous quarterly dividend of $0.28. Steris Plc’s payout ratio is 80.00%.
In other Steris Plc news, VP Sudhir K. Pahwa sold 800 shares of the business’s stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $77.28, for a total transaction of $61,824.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Daniel A. Carestio sold 4,745 shares of the business’s stock in a transaction that occurred on Tuesday, June 13th. The shares were sold at an average price of $80.08, for a total value of $379,979.60. The disclosure for this sale can be found here. Insiders have sold 33,084 shares of company stock valued at $2,668,633 in the last 90 days. Company insiders own 2.55% of the company’s stock.
About Steris Plc
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.